The Insulin Price Crisis in the U.S.A.

Insulin is as necessary to a person with type 1 diabetes as oxygen is to any human being, and there are over 7 million Americans that rely on injected insulin to stay alive and healthy.

  • Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
  • Spending by patients with type 1 diabetes on insulin nearly doubled from 2012 to 2016, increasing from $2900 to $5700.
  • One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.

This crisis is forcing patients to resort to drastic measures to stay alive. Countless people have to choose between buying their essential insulin and paying their rent, buying food, or other unthinkable sacrifices

T1International and patient advocates have been working on insulin access and affordability issues since 2013. We will keep raising our voices to ensure we are heard! If the millions of Americans that are insulin dependent speak up, insulin manufacturers and government representatives will take action to ensure insulin is affordable and accessible for all.



See Statments

vial & syringes

USA Stories

Read our Stories


For Legislators

Learn More

Insulin human right

USA Action

Take Action

Chapter action

USA Chapters

Join a Chapter

Eli Lilly Demonstration Vigil to Remember Lives Lost from Rationing Insulin

We're holding our 3rd event outside of Eli Lilly on September 14th in Indianapolis at 8pm. It will take the form of a vigil to remember the lives lost due to the high cost of insulin.

We demonstrated in 2017 and 2018 outside of Eli Lilly and held days of action to call representatives and senators at the federal and state level. Advocates around the USA continue to inform, educate and advocate for lowering insulin prices and increasing access in America.

Our representatives need to know how essential it is for them to tackle the issue of insulin access and affordability and that the high prices being charged by Novo Nordisk, Eli Lilly and Sanofi for insulin are unacceptable. You can get engaged right away by using the resources and information on this page.